nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—AHR—liver cancer	0.835	1	CbGaD
Nimodipine—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00269	0.0561	CcSEcCtD
Nimodipine—Haematoma—Sorafenib—liver cancer	0.00251	0.0525	CcSEcCtD
Nimodipine—Cardiac failure congestive—Sorafenib—liver cancer	0.00126	0.0264	CcSEcCtD
Nimodipine—Hyponatraemia—Sorafenib—liver cancer	0.00115	0.0241	CcSEcCtD
Nimodipine—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.00114	0.0238	CcSEcCtD
Nimodipine—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.00106	0.0221	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Sorafenib—liver cancer	0.00101	0.0211	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.001	0.021	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.000929	0.0194	CcSEcCtD
Nimodipine—Jaundice—Sorafenib—liver cancer	0.000861	0.018	CcSEcCtD
Nimodipine—Hepatobiliary disease—Sorafenib—liver cancer	0.000835	0.0175	CcSEcCtD
Nimodipine—Ileus—Epirubicin—liver cancer	0.000825	0.0172	CcSEcCtD
Nimodipine—Ileus—Doxorubicin—liver cancer	0.000763	0.0159	CcSEcCtD
Nimodipine—Flushing—Sorafenib—liver cancer	0.000736	0.0154	CcSEcCtD
Nimodipine—Cardiac disorder—Sorafenib—liver cancer	0.000736	0.0154	CcSEcCtD
Nimodipine—Angiopathy—Sorafenib—liver cancer	0.000719	0.015	CcSEcCtD
Nimodipine—Immune system disorder—Sorafenib—liver cancer	0.000716	0.015	CcSEcCtD
Nimodipine—Muscle spasms—Sorafenib—liver cancer	0.000664	0.0139	CcSEcCtD
Nimodipine—Anaemia—Sorafenib—liver cancer	0.000638	0.0133	CcSEcCtD
Nimodipine—Hypertension—Sorafenib—liver cancer	0.000596	0.0125	CcSEcCtD
Nimodipine—Myalgia—Sorafenib—liver cancer	0.000588	0.0123	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000584	0.0122	CcSEcCtD
Nimodipine—Clevidipine—CYP2E1—liver cancer	0.00058	0.212	CrCbGaD
Nimodipine—Fluid retention—Epirubicin—liver cancer	0.000554	0.0116	CcSEcCtD
Nimodipine—Nervous system disorder—Sorafenib—liver cancer	0.000552	0.0115	CcSEcCtD
Nimodipine—Thrombocytopenia—Sorafenib—liver cancer	0.000552	0.0115	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.00054	0.0113	CcSEcCtD
Nimodipine—Nilvadipine—CYP2E1—liver cancer	0.00052	0.19	CrCbGaD
Nimodipine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000513	0.0107	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—liver cancer	0.000513	0.0107	CcSEcCtD
Nimodipine—Dyspnoea—Sorafenib—liver cancer	0.000502	0.0105	CcSEcCtD
Nimodipine—Phlebitis—Epirubicin—liver cancer	0.000492	0.0103	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000487	0.0102	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000486	0.0102	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—liver cancer	0.000467	0.00976	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—liver cancer	0.000455	0.00951	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000451	0.00942	CcSEcCtD
Nimodipine—Amlodipine—CYP1A1—liver cancer	0.000442	0.162	CrCbGaD
Nimodipine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000432	0.00903	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—liver cancer	0.000425	0.00889	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000424	0.00886	CcSEcCtD
Nimodipine—Hypersensitivity—Sorafenib—liver cancer	0.000415	0.00868	CcSEcCtD
Nimodipine—Nifedipine—CYP2E1—liver cancer	0.0004	0.147	CrCbGaD
Nimodipine—Pruritus—Sorafenib—liver cancer	0.000399	0.00833	CcSEcCtD
Nimodipine—Nifedipine—CYP1A1—liver cancer	0.000395	0.145	CrCbGaD
Nimodipine—Nicardipine—CYP2E1—liver cancer	0.000394	0.144	CrCbGaD
Nimodipine—Hyponatraemia—Doxorubicin—liver cancer	0.000394	0.00823	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000392	0.00819	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—liver cancer	0.000391	0.00818	CcSEcCtD
Nimodipine—Diarrhoea—Sorafenib—liver cancer	0.000385	0.00806	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000374	0.00781	CcSEcCtD
Nimodipine—Dizziness—Sorafenib—liver cancer	0.000373	0.00779	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—liver cancer	0.000362	0.00756	CcSEcCtD
Nimodipine—Vomiting—Sorafenib—liver cancer	0.000358	0.00749	CcSEcCtD
Nimodipine—Rash—Sorafenib—liver cancer	0.000355	0.00743	CcSEcCtD
Nimodipine—Dermatitis—Sorafenib—liver cancer	0.000355	0.00742	CcSEcCtD
Nimodipine—Headache—Sorafenib—liver cancer	0.000353	0.00738	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000346	0.00723	CcSEcCtD
Nimodipine—Nausea—Sorafenib—liver cancer	0.000335	0.007	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—liver cancer	0.000318	0.00665	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—liver cancer	0.000309	0.00645	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—liver cancer	0.000298	0.00624	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—liver cancer	0.000294	0.00615	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—liver cancer	0.000293	0.00613	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000286	0.00597	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—liver cancer	0.000276	0.00577	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—liver cancer	0.000272	0.00569	CcSEcCtD
Nimodipine—Flushing—Epirubicin—liver cancer	0.000272	0.00569	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—liver cancer	0.000271	0.00567	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—liver cancer	0.000266	0.00556	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—liver cancer	0.000265	0.00553	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—liver cancer	0.000252	0.00526	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—liver cancer	0.000252	0.00526	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—liver cancer	0.000246	0.00514	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—liver cancer	0.000245	0.00513	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—liver cancer	0.000245	0.00512	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—liver cancer	0.000236	0.00493	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—liver cancer	0.000227	0.00474	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—liver cancer	0.000225	0.00471	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—liver cancer	0.00022	0.0046	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—liver cancer	0.000218	0.00456	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—liver cancer	0.000217	0.00454	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—liver cancer	0.000209	0.00436	CcSEcCtD
Nimodipine—Oedema—Epirubicin—liver cancer	0.000208	0.00435	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—liver cancer	0.000204	0.00427	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—liver cancer	0.000204	0.00426	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—liver cancer	0.000204	0.00426	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—liver cancer	0.000203	0.00425	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—liver cancer	0.000201	0.00421	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—liver cancer	0.000201	0.0042	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—liver cancer	0.000195	0.00407	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—liver cancer	0.000193	0.00403	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00019	0.00397	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—liver cancer	0.000189	0.00395	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—liver cancer	0.000189	0.00394	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—liver cancer	0.000188	0.00393	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—liver cancer	0.000186	0.00389	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—liver cancer	0.000186	0.00388	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—liver cancer	0.00018	0.00376	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00018	0.00376	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000176	0.00367	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—liver cancer	0.000172	0.00359	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000166	0.00348	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—liver cancer	0.000153	0.00321	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—liver cancer	0.000147	0.00308	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—liver cancer	0.000142	0.00298	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—liver cancer	0.000142	0.00297	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—liver cancer	0.000138	0.00288	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—liver cancer	0.000136	0.00285	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—liver cancer	0.000132	0.00277	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—liver cancer	0.000132	0.00276	CcSEcCtD
Nimodipine—Rash—Epirubicin—liver cancer	0.000131	0.00274	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—liver cancer	0.000131	0.00274	CcSEcCtD
Nimodipine—Headache—Epirubicin—liver cancer	0.00013	0.00273	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—liver cancer	0.000127	0.00266	CcSEcCtD
Nimodipine—Nausea—Epirubicin—liver cancer	0.000124	0.00259	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—liver cancer	0.000122	0.00256	CcSEcCtD
Nimodipine—Rash—Doxorubicin—liver cancer	0.000121	0.00254	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—liver cancer	0.000121	0.00254	CcSEcCtD
Nimodipine—Headache—Doxorubicin—liver cancer	0.000121	0.00252	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—liver cancer	0.000114	0.00239	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—PPARG—liver cancer	4.89e-05	0.000428	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTA1—liver cancer	4.88e-05	0.000428	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	4.87e-05	0.000427	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KDR—liver cancer	4.83e-05	0.000423	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NAT2—liver cancer	4.83e-05	0.000423	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TGFB1—liver cancer	4.81e-05	0.000421	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MAPK14—liver cancer	4.8e-05	0.000421	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—liver cancer	4.77e-05	0.000418	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP2—liver cancer	4.74e-05	0.000415	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—liver cancer	4.73e-05	0.000415	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—liver cancer	4.73e-05	0.000414	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—liver cancer	4.73e-05	0.000414	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARA—liver cancer	4.7e-05	0.000411	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTM1—liver cancer	4.69e-05	0.000411	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TGFB1—liver cancer	4.68e-05	0.00041	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—HPGDS—liver cancer	4.64e-05	0.000407	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HPGDS—liver cancer	4.64e-05	0.000406	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALDOB—liver cancer	4.63e-05	0.000406	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—liver cancer	4.6e-05	0.000403	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—IL6—liver cancer	4.53e-05	0.000397	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP2—liver cancer	4.49e-05	0.000393	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—liver cancer	4.49e-05	0.000393	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—liver cancer	4.48e-05	0.000393	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—liver cancer	4.45e-05	0.00039	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1A1—liver cancer	4.45e-05	0.00039	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—liver cancer	4.45e-05	0.00039	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CRABP1—liver cancer	4.42e-05	0.000387	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HPGDS—liver cancer	4.39e-05	0.000385	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UGDH—liver cancer	4.38e-05	0.000383	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—liver cancer	4.37e-05	0.000383	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MAPK14—liver cancer	4.34e-05	0.00038	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—liver cancer	4.33e-05	0.00038	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—liver cancer	4.3e-05	0.000376	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR1—liver cancer	4.25e-05	0.000373	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—liver cancer	4.25e-05	0.000372	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—liver cancer	4.24e-05	0.000371	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RAF1—liver cancer	4.2e-05	0.000368	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—AKT1—liver cancer	4.18e-05	0.000366	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—liver cancer	4.16e-05	0.000364	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—liver cancer	4.15e-05	0.000364	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—liver cancer	4.15e-05	0.000363	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSMD10—liver cancer	4.13e-05	0.000362	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSMA4—liver cancer	4.13e-05	0.000362	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EPT1—liver cancer	4.11e-05	0.000361	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARA—liver cancer	4.07e-05	0.000356	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GOT2—liver cancer	4.02e-05	0.000352	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RAF1—liver cancer	3.98e-05	0.000348	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—liver cancer	3.94e-05	0.000346	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSMD10—liver cancer	3.91e-05	0.000343	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSMA4—liver cancer	3.91e-05	0.000343	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TAT—liver cancer	3.9e-05	0.000342	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—liver cancer	3.88e-05	0.00034	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HPGDS—liver cancer	3.86e-05	0.000338	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—liver cancer	3.81e-05	0.000334	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GOT2—liver cancer	3.81e-05	0.000334	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	3.79e-05	0.000332	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—liver cancer	3.78e-05	0.000332	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP2E1—liver cancer	3.78e-05	0.000331	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—liver cancer	3.78e-05	0.000331	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	3.73e-05	0.000327	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—liver cancer	3.73e-05	0.000327	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—liver cancer	3.73e-05	0.000327	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—liver cancer	3.7e-05	0.000324	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—liver cancer	3.68e-05	0.000323	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—liver cancer	3.65e-05	0.00032	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—liver cancer	3.63e-05	0.000318	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—IL6—liver cancer	3.62e-05	0.000317	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—IL6—liver cancer	3.62e-05	0.000317	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—liver cancer	3.61e-05	0.000316	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP2E1—liver cancer	3.58e-05	0.000314	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—liver cancer	3.56e-05	0.000312	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYCS—liver cancer	3.54e-05	0.00031	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—IL6—liver cancer	3.52e-05	0.000309	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SERPINE1—liver cancer	3.5e-05	0.000306	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RAF1—liver cancer	3.49e-05	0.000306	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CG—liver cancer	3.48e-05	0.000305	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GGT1—liver cancer	3.48e-05	0.000305	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GGT1—liver cancer	3.47e-05	0.000304	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GOT1—liver cancer	3.47e-05	0.000304	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—liver cancer	3.44e-05	0.000302	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSMD10—liver cancer	3.44e-05	0.000301	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSMA4—liver cancer	3.44e-05	0.000301	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TGFB1—liver cancer	3.43e-05	0.0003	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—liver cancer	3.37e-05	0.000296	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—liver cancer	3.36e-05	0.000295	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYCS—liver cancer	3.35e-05	0.000294	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GOT2—liver cancer	3.35e-05	0.000293	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—AKT1—liver cancer	3.34e-05	0.000293	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GOT1—liver cancer	3.29e-05	0.000288	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GGT1—liver cancer	3.29e-05	0.000288	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—AKT1—liver cancer	3.25e-05	0.000285	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—liver cancer	3.24e-05	0.000284	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—liver cancer	3.2e-05	0.00028	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—liver cancer	3.2e-05	0.00028	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—liver cancer	3.17e-05	0.000278	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—liver cancer	3.17e-05	0.000278	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—liver cancer	3.17e-05	0.000278	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP2E1—liver cancer	3.15e-05	0.000276	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—liver cancer	3.12e-05	0.000274	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—liver cancer	3.12e-05	0.000273	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—IL6—liver cancer	3.1e-05	0.000272	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	3.08e-05	0.00027	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HMOX1—liver cancer	3.08e-05	0.000269	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—liver cancer	3.07e-05	0.000269	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CD—liver cancer	3.06e-05	0.000268	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—liver cancer	3.03e-05	0.000266	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—liver cancer	3.02e-05	0.000265	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ALB—liver cancer	3.02e-05	0.000265	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—liver cancer	3e-05	0.000263	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—liver cancer	2.96e-05	0.00026	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—liver cancer	2.95e-05	0.000259	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYCS—liver cancer	2.94e-05	0.000258	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—IL6—liver cancer	2.94e-05	0.000257	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TGFB1—liver cancer	2.94e-05	0.000257	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HMOX1—liver cancer	2.91e-05	0.000255	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GGT1—liver cancer	2.89e-05	0.000253	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GOT1—liver cancer	2.89e-05	0.000253	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—liver cancer	2.87e-05	0.000251	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—liver cancer	2.87e-05	0.000251	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	2.83e-05	0.000248	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TGFB1—liver cancer	2.78e-05	0.000244	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—liver cancer	2.74e-05	0.00024	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	2.72e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—liver cancer	2.72e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1A1—liver cancer	2.72e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—liver cancer	2.71e-05	0.000238	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—liver cancer	2.7e-05	0.000236	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—liver cancer	2.7e-05	0.000236	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	2.68e-05	0.000235	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CB—liver cancer	2.67e-05	0.000234	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—liver cancer	2.66e-05	0.000233	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GLUL—liver cancer	2.65e-05	0.000232	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CPT1B—liver cancer	2.65e-05	0.000232	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—liver cancer	2.64e-05	0.000231	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—liver cancer	2.6e-05	0.000228	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—liver cancer	2.59e-05	0.000227	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—IL6—liver cancer	2.58e-05	0.000226	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—IL6—liver cancer	2.58e-05	0.000226	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—liver cancer	2.58e-05	0.000226	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1A1—liver cancer	2.57e-05	0.000225	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMOX1—liver cancer	2.56e-05	0.000224	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NR1H4—liver cancer	2.56e-05	0.000224	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—liver cancer	2.53e-05	0.000222	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA3—liver cancer	2.51e-05	0.00022	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARA—liver cancer	2.48e-05	0.000218	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TGFB1—liver cancer	2.44e-05	0.000214	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—liver cancer	2.4e-05	0.00021	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—liver cancer	2.38e-05	0.000209	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—AKT1—liver cancer	2.38e-05	0.000209	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARA—liver cancer	2.35e-05	0.000206	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—liver cancer	2.31e-05	0.000203	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA4—liver cancer	2.3e-05	0.000201	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—liver cancer	2.28e-05	0.0002	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—liver cancer	2.26e-05	0.000198	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1A1—liver cancer	2.26e-05	0.000198	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA2—liver cancer	2.24e-05	0.000196	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—IL6—liver cancer	2.21e-05	0.000194	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—liver cancer	2.21e-05	0.000194	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—liver cancer	2.19e-05	0.000192	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTA1—liver cancer	2.16e-05	0.000189	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAT2—liver cancer	2.14e-05	0.000187	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—liver cancer	2.13e-05	0.000186	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—liver cancer	2.11e-05	0.000185	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—IL6—liver cancer	2.1e-05	0.000184	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARA—liver cancer	2.07e-05	0.000181	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—liver cancer	2.05e-05	0.00018	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDOB—liver cancer	2.05e-05	0.00018	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—AKT1—liver cancer	2.04e-05	0.000179	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UGDH—liver cancer	2.03e-05	0.000178	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—liver cancer	2.01e-05	0.000177	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CRABP1—liver cancer	1.95e-05	0.000171	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—liver cancer	1.94e-05	0.00017	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—AKT1—liver cancer	1.93e-05	0.000169	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—liver cancer	1.92e-05	0.000169	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EPT1—liver cancer	1.91e-05	0.000168	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CD—liver cancer	1.87e-05	0.000164	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALB—liver cancer	1.85e-05	0.000162	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—IL6—liver cancer	1.84e-05	0.000161	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TAT—liver cancer	1.81e-05	0.000159	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CD—liver cancer	1.77e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—liver cancer	1.77e-05	0.000155	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALB—liver cancer	1.75e-05	0.000153	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—liver cancer	1.71e-05	0.00015	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HPGDS—liver cancer	1.71e-05	0.00015	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—AKT1—liver cancer	1.7e-05	0.000149	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CB—liver cancer	1.63e-05	0.000143	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—liver cancer	1.63e-05	0.000143	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CD—liver cancer	1.56e-05	0.000136	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CB—liver cancer	1.54e-05	0.000135	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALB—liver cancer	1.54e-05	0.000135	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—AKT1—liver cancer	1.53e-05	0.000134	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSMD10—liver cancer	1.52e-05	0.000133	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSMA4—liver cancer	1.52e-05	0.000133	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GOT2—liver cancer	1.48e-05	0.00013	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2E1—liver cancer	1.39e-05	0.000122	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CB—liver cancer	1.36e-05	0.000119	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—AKT1—liver cancer	1.33e-05	0.000116	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYCS—liver cancer	1.3e-05	0.000114	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GGT1—liver cancer	1.28e-05	0.000112	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GOT1—liver cancer	1.28e-05	0.000112	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GLUL—liver cancer	1.23e-05	0.000108	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CPT1B—liver cancer	1.23e-05	0.000108	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NR1H4—liver cancer	1.19e-05	0.000104	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA3—liver cancer	1.17e-05	0.000102	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—liver cancer	1.15e-05	0.000101	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMOX1—liver cancer	1.13e-05	9.93e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA4—liver cancer	1.07e-05	9.36e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—liver cancer	1.06e-05	9.25e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA2—liver cancer	1.04e-05	9.13e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTA1—liver cancer	1e-05	8.8e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1A1—liver cancer	1e-05	8.77e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—liver cancer	9.94e-06	8.71e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT2—liver cancer	9.93e-06	8.71e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDOB—liver cancer	9.52e-06	8.35e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—liver cancer	9.41e-06	8.25e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—liver cancer	9.33e-06	8.17e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARA—liver cancer	9.15e-06	8.02e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CRABP1—liver cancer	9.09e-06	7.96e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—liver cancer	8.27e-06	7.25e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—AKT1—liver cancer	8.12e-06	7.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPGDS—liver cancer	7.94e-06	6.96e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—liver cancer	7.84e-06	6.87e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—AKT1—liver cancer	7.69e-06	6.74e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—liver cancer	7.56e-06	6.63e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSMA4—liver cancer	7.08e-06	6.2e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSMD10—liver cancer	7.08e-06	6.2e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CD—liver cancer	6.89e-06	6.04e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GOT2—liver cancer	6.89e-06	6.03e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALB—liver cancer	6.8e-06	5.96e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—AKT1—liver cancer	6.76e-06	5.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2E1—liver cancer	6.47e-06	5.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYCS—liver cancer	6.06e-06	5.31e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CB—liver cancer	6e-06	5.26e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GGT1—liver cancer	5.94e-06	5.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GOT1—liver cancer	5.94e-06	5.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—liver cancer	5.34e-06	4.68e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMOX1—liver cancer	5.27e-06	4.61e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—liver cancer	4.91e-06	4.3e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1A1—liver cancer	4.65e-06	4.08e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—liver cancer	4.34e-06	3.8e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARA—liver cancer	4.25e-06	3.73e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—liver cancer	3.66e-06	3.21e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—liver cancer	3.64e-06	3.19e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—liver cancer	3.52e-06	3.08e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CD—liver cancer	3.2e-06	2.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALB—liver cancer	3.16e-06	2.77e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—AKT1—liver cancer	2.99e-06	2.62e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.79e-06	2.45e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.7e-06	1.49e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—AKT1—liver cancer	1.39e-06	1.22e-05	CbGpPWpGaD
